Poseida Therapeutics, Inc. (PSTX)
9.50
0.00 (0.00%)
USD |
NASDAQ |
Jan 08, 16:00
Poseida Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.9486 |
| June 30, 2024 | 1.376 |
| March 31, 2024 | 0.9996 |
| December 31, 2023 | 0.8237 |
| September 30, 2023 | 0.6976 |
| June 30, 2023 | 0.6436 |
| March 31, 2023 | 0.5578 |
| December 31, 2022 | 0.4731 |
| September 30, 2022 | 0.419 |
| June 30, 2022 | 1.391 |
| March 31, 2022 | 0.8987 |
| December 31, 2021 | 0.3918 |
| September 30, 2021 | 0.4004 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.3269 |
| March 31, 2021 | 0.2718 |
| December 31, 2020 | 0.2264 |
| September 30, 2020 | 0.199 |
| June 30, 2020 | 0.4492 |
| March 31, 2020 | 1.217 |
| December 31, 2019 | 0.401 |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -4.482 |
| December 31, 2017 | 1.129 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Abeona Therapeutics, Inc. | 0.1552 |
| America Great Health | -0.6512 |
| Acumen Pharmaceuticals, Inc. | 0.5526 |
| Aardvark Therapeutics, Inc. | 0.0091 |